EUVIMEDEUVIMED entdecken
Crossref

Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study

Andrea Aiello, Daniela Ritrovato, Claudia Pitotti

Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish · 2018

DOI: 10.1177/2284240318804808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2018. Verfasst von Andrea Aiello und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Novartis Farma Italy.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Novartis Farma Italy

Zitieren

APA

Aiello, A., Ritrovato, D., & Pitotti, C. (2018). Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish. https://doi.org/10.1177/2284240318804808

Vancouver

Aiello A, Ritrovato D, Pitotti C. Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish. 2018. doi:10.1177/2284240318804808

BibTeX
@article{Aiello2018,
  author = {Aiello, Andrea and Ritrovato, Daniela and Pitotti, Claudia},
  title = {Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study},
  journal = {Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish},
  year = {2018},
  doi = {10.1177/2284240318804808}
}
Kostenlos starten →